FindTrial
Sign In

Challenges in Diagnosing and Treating Rare cancer situtated deep inside abdomen: Our Hospital?s Experience

Retroperitoneal Paragangliomas- Diagnostic and Therapeutic Challenges: A single centre experience - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093596
Enrollment
30
Registered
2025-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C480- Malignant neoplasm of retroperitoneum

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients who underwent surgery for retroperitoneal paraganglioma were included

Exclusion criteria

Exclusion criteria: Patients with incomplete medical records

Design outcomes

Primary

MeasureTime frame
Median and 5-year OS and DFSTimepoint: 5-year from the date of surgery—

Secondary

MeasureTime frame
Postoperative morbidity and mortality ratesTimepoint: 30 days, 90 days, 1 yrs, 3 yrs and 5-year from the date of surgery;Biochemical cure ratesTimepoint: 30 days, 90 days, 1 yrs, 3 yrs from the date of surgery;Long-term cardiovascular complicationsTimepoint: 1 yrs, 3 yrs and 5-year from the date of surgery;Quality of Life at 1st follow-upTimepoint: 30 days from the date of surgery;Proportion of malignant transformationTimepoint: 90 days, 1 yrs, 3 yrs and 5-year from the date of surgery—

Countries

India

Contacts

Public ContactDr Shraddha Patkar

Tata Memorial Hospital

drshraddhapatkar@gmail.com9820074818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026